Search
Nutriband Inc
NTRBAdd to Watchlist
3.090USD
-0.100-3.13%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
37.56MMarket Cap
LossP/E TTM
More Details of Nutriband Inc Company
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Nutriband Inc Info
Ticker SymbolNTRB
Company nameNutriband Inc
IPO dateJun 20, 2017
CEOMelnik (Serguei)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJun 20
Address121 S Orange Ave Ste 1500
CityORLANDO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32801-3241
Phone14073776695
Websitehttps://nutriband.com/
Ticker SymbolNTRB
IPO dateJun 20, 2017
CEOMelnik (Serguei)
Company Executives of Nutriband Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
FAQs
Who are the top five shareholders of Nutriband Inc?
The top five shareholders of Nutriband Inc are: Mr. Serguei Melnik
How many institutions hold shares of Nutriband Inc (NTRB)?
As of 2026Q1, 45 institutions hold shares of Nutriband Inc, with a combined market value of approximately 579.57K, accounting for 4.77% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 106153.00.